Company intelligence / Profile preview

Southern California Eye Institute

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

SCEI provides top-tier clinical eye care and pursues research in stem cell therapy, novel glaucoma devices, artificial retinas, drug delivery, functional imaging, and population-based studies. Several NIH- and WHO-funded epidemiological studies have informed clinical practice and health policy

Therapeutic areas: Ophthalmology
Modalities: Stem cell therapyArtificial retina (device)Bioelectronic implants (device)Drug delivery device
Industry: Academic Hospital/University/Research

Partnerships

CHA Health SystemsWorld Health Organization (research)National Institutes of Health (research)

Beyond the preview

Go deeper on Southern California Eye Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Southern California Eye Institute.

Explore the full profile